Related Experiment Video
Updated: Aug 9, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases
M Jäättelä1, D Wissing, K Kokholm
1Apoptosis Laboratory, Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
Abstract:
The major heat shock protein, Hsp70, is an effective inhibitor of apoptosis. To study its mechanism of action, we created tumor cell lines with altered Hsp70 levels. The expression levels of Hsp70 in the cells obtained correlated well with their survival following treatments with tumor necrosis factor, staurosporine and doxorubicin. Surprisingly, the surviving Hsp70-expressing cells responded to the apoptotic stimuli by activation of stress-activated protein kinases, generation of free radicals, early disruption of mitochondrial transmembrane potential, release of cytochrome c from mitochondria and activation of caspase-3-like proteases in a manner essentially similar to that of the dying cells with low Hsp70 levels. However, Hsp70 inhibited late caspase-dependent events such as activation of cytosolic phospholipase A2 and changes in nuclear morphology. Furthermore, Hsp70 conferred significant protection against cell death induced by enforced expression of caspase-3. Thus, Hsp70 rescues cells from apoptosis later in the death signaling pathway than any known anti-apoptotic protein, making it a tempting target for therapeutic interventions.
Insights
Heat shock protein 70 (Hsp70) inhibits apoptosis by blocking late-stage cell death events. This major heat shock protein offers a novel therapeutic target for preventing programmed cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Apoptosis, or programmed cell death, is a critical cellular process.
- Heat shock proteins (HSPs) are known to play roles in cellular stress response and survival.
- Hsp70 is a major heat shock protein implicated in inhibiting apoptosis.
Purpose of the Study:
- To investigate the mechanism by which Hsp70 inhibits apoptosis.
- To determine the specific stage of the apoptotic pathway affected by Hsp70.
- To evaluate Hsp70 as a potential therapeutic target for modulating cell death.
Main Methods:
- Generation of tumor cell lines with varying Hsp70 expression levels.
- Treatment of cell lines with apoptotic stimuli (TNF, staurosporine, doxorubicin).
- Analysis of apoptotic markers including caspase activation, mitochondrial potential, and nuclear morphology.
Main Results:
- Hsp70 expression levels correlated with cell survival following apoptotic stimuli.
- Hsp70-expressing cells exhibited early apoptotic events similar to low Hsp70 cells.
- Hsp70 specifically inhibited late, caspase-dependent apoptotic events and protected against caspase-3-induced cell death.
Conclusions:
- Hsp70 acts as an anti-apoptotic factor by interfering with late-stage apoptotic signaling.
- Hsp70's mechanism of action occurs later in the apoptotic pathway than other known inhibitors.
- Hsp70 represents a promising therapeutic target for controlling apoptosis in various conditions.
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The JAK-STAT Signaling Pathway

